Search

everythinglearnresearchcommunity

for

Search:↓

ErbB2 signaling is crucial for skin cell growth and cancer development in mice.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Bone marrow-derived cells can lead to skin inflammation and tumors in mice.

Alopecia areata involves unique activation of certain immune cells.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

γδ T cells adapt uniquely to different tissues in mice.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

HPV8 causes skin cancer by expanding specific skin stem cells.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Keratin 15 cells from hair follicles help develop and maintain skin tumors in mice.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Stem cell behavior varies with stimuli, and lineage changes can happen without affecting stem cell division.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

A method was developed to grow millions of hair cells from a single hair for research and storage.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

CXCR2 in skin cells promotes tumor growth.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.